Valuation: INSTITUT

Market Cap 4.4B 57.23M 50.03M 45.98M 42.86M 81.29M 5.45B 82.53M 552M 215M 2.68B 215M 210M 9.23B P/E 2024
25.7x
P/E 2025 46.2x
Enterprise Value 4.64B 60.28M 52.7M 48.43M 45.14M 85.62M 5.74B 86.92M 581M 226M 2.82B 226M 221M 9.72B EV / Sales 2024
3.02x
EV / Sales 2025 2.7x
Free-Float
17.07%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 68 22/08/2010
Director/Board Member 47 08/01/2014
Director/Board Member 45 31/12/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%+0.36%+55.30%+50.09% 134B
+4.39%+4.80%+9.01%+37.95% 91.07B
+0.74%+6.55%+0.09%+63.70% 27.34B
-0.14%+2.78%+21.93%+55.03% 23.88B
-0.83%+0.14%-20.41%-27.08% 19.96B
+6.55%+7.79%+18.79%+150.42% 17.55B
+3.02%+8.23%+64.78%+133.12% 15.08B
+0.62%+3.00%+1.59%+6.78% 15.2B
-0.12%+0.59%-14.16%-5.86% 12.63B
Average +1.57%+4.65%+15.21%+51.57% 39.59B
Weighted average by Cap. +1.56%+3.50%+26.61%+48.66%

Financials

2024 2025
Net sales 1.52B 19.79M 17.3M 15.9M 14.82M 28.1M 1.88B 28.53M 191M 74.18M 926M 74.27M 72.67M 3.19B 1.72B 22.32M 19.51M 17.93M 16.71M 31.7M 2.12B 32.18M 215M 83.68M 1.04B 83.77M 81.97M 3.6B
Net income 215M 2.79M 2.44M 2.25M 2.09M 3.97M 266M 4.03M 26.95M 10.48M 131M 10.49M 10.26M 451M 96.95M 1.26M 1.1M 1.01M 944K 1.79M 120M 1.82M 12.16M 4.73M 59.01M 4.73M 4.63M 203M
Net Debt 199M 2.59M 2.26M 2.08M 1.94M 3.68M 247M 3.73M 24.98M 9.71M 121M 9.72M 9.51M 418M 234M 3.05M 2.67M 2.45M 2.28M 4.33M 290M 4.4M 29.41M 11.43M 143M 11.45M 11.2M 492M
Logo INSTITUT
Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.
Employees
-